UBS analyst Eliana Merle lowered the firm’s price target on Apellis (APLS) to $45 from $74 and keeps a Buy rating on the shares. The firm says the company’s Q3 resent expectatoins.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.